Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (175) Arrow Down
Filter Results: (175) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (1,059)
    • Faculty Publications  (175)

    Show Results For

    • All HBS Web  (1,059)
      • Faculty Publications  (175)

      Health Testing and TrialsRemove Health Testing and Trials →

      ← Page 9 of 175 Results

      Are you looking for?

      →Search All HBS Web
      • November 2003 (Revised September 2008)
      • Case

      Circle Gastroenterology Products (A)

      By: Regina E. Herzlinger and James Weber
      A new, minimally invasive medical device has achieved only one-third of its budget. Was the problem one of marketing strategy, sales, reimbursement, and/or clinical trials? View Details
      Keywords: Health Testing and Trials; Marketing Strategy; Product Marketing; Sales; Medical Devices and Supplies Industry
      Citation
      Educators
      Purchase
      Related
      Herzlinger, Regina E., and James Weber. "Circle Gastroenterology Products (A)." Harvard Business School Case 304-052, November 2003. (Revised September 2008.)
      • August 2003 (Revised August 2024)
      • Case

      Fighting the Battle of the Bulge—Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment

      By: Regina E. Herzlinger and John McDonough
      Many health care innovations appear successful; but fail. This is the first case in the Innovating Health Care course that investigates how to create successful health care innovations. It is part of the first module in the course. This module focuses on how to... View Details
      Keywords: Three Pillars; Industry Analysis; Health Care and Treatment; Innovation and Invention; Innovation and Management; Medical Specialties; Health Industry
      Citation
      Educators
      Purchase
      Related
      Herzlinger, Regina E., and John McDonough. "Fighting the Battle of the Bulge—Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment." Harvard Business School Case 304-009, August 2003. (Revised August 2024.)
      • April 2003 (Revised October 2004)
      • Case

      Novartis: The Challenge of Success (A)

      By: Sandra J. Sucher and Stacy McManus
      Preliminary results from Phase 1 clinical trials of a newly developed compound, STI571, showed that 31 out of 31 patients with chronic myelogenous leukemia (CML) had their blood counts return to normal. In the world of oncology, this was unheard of. This was the... View Details
      Keywords: Decision Making; Health Testing and Trials; Innovation and Invention; Markets; Distribution; Product Development; Production; Problems and Challenges; Research; Research and Development; Complexity; Biotechnology Industry; Pharmaceutical Industry
      Citation
      Educators
      Purchase
      Related
      Sucher, Sandra J., and Stacy McManus. "Novartis: The Challenge of Success (A)." Harvard Business School Case 603-043, April 2003. (Revised October 2004.)
      • December 2002
      • Teaching Note

      Abgenix and the XenoMouse (TN)

      By: John T. Gourville
      Teaching Note for (501-061). View Details
      Keywords: Health Testing and Trials; Decision Choices and Conditions; Sales; Product Development; Joint Ventures; Health Industry; Health Industry
      Citation
      Purchase
      Related
      Gourville, John T. "Abgenix and the XenoMouse (TN)." Harvard Business School Teaching Note 503-046, December 2002.
      • January 2001
      • Case

      Abgenix and the XenoMouse

      By: Robert J. Dolan
      Abgenix has a unique method for generating antibodies useful in treating a number of diseases, including cancer. In early 2000, the company's cancer has performed very well in animal testing and is moving to early stage human testing. Abgenix must decide whether to... View Details
      Keywords: Product Development; Marketing Strategy; Health Testing and Trials; Risk and Uncertainty; Technological Innovation; Innovation Strategy; Science-Based Business; Biotechnology Industry
      Citation
      Educators
      Purchase
      Related
      Dolan, Robert J. "Abgenix and the XenoMouse." Harvard Business School Case 501-061, January 2001.
      • May 1999 (Revised July 2000)
      • Teaching Note

      Reading Rehabilitation Hospital: Implementing Patient-Focused Care TN

      By: Jody H. Gittell and Sandra J. Sucher
      Teaching Note for (9-898-172). A rewritten version of an earlier teaching note. View Details
      Keywords: Health; Health Care and Treatment; Medical Specialties; Health Testing and Trials; Valuation; Service Operations; Balance and Stability; Production; Demand and Consumers; Risk and Uncertainty; Technology; Health Industry
      Citation
      Purchase
      Related
      Gittell, Jody H., and Sandra J. Sucher. "Reading Rehabilitation Hospital: Implementing Patient-Focused Care TN." Harvard Business School Teaching Note 899-139, May 1999. (Revised July 2000.)
      • July 1998
      • Supplement

      Bell Atlantic in Union City

      By: Rosabeth M. Kanter
      In this pioneering project to wire a school for the Internet and put computers in students' homes, Bell Atlantic combined its need for a beta site for a technology trial with the school reform efforts of the Union City, New Jersey public schools, under the leadership... View Details
      Keywords: Business Model; Social Enterprise; Internet and the Web; Education; Business and Community Relations; Education Industry; New Jersey
      Citation
      Purchase
      Related
      Kanter, Rosabeth M. "Bell Atlantic in Union City." Harvard Business School Video Supplement 399-501, July 1998.
      • 1996
      • Chapter

      The Determinants of Research Productivity in Ethical Drug Discovery

      By: Rebecca M. Henderson and Ian Cockburn
      Keywords: Ethics; Health Testing and Trials; Research and Development; Performance Productivity; Pharmaceutical Industry
      Citation
      Related
      Henderson, Rebecca M., and Ian Cockburn. "The Determinants of Research Productivity in Ethical Drug Discovery." In Competitive Strategies in the Pharmaceutical Industry, edited by Robert B. Helms. Washington, D.C.: AEI Press, 1996.
      • May 1993
      • Case

      Patient Transfusion Services Lab of Central Blood Bank

      By: James L. Heskett
      The vice president of the Lab and Clinical Services at Central Blood Bank is faced with the challenge of convincing a hospital to use economical shared patient transfusion testing services. View Details
      Keywords: Health Care and Treatment; Quality; Service Operations; Mathematical Methods; Customer Satisfaction; Health Industry
      Citation
      Educators
      Purchase
      Related
      Heskett, James L. "Patient Transfusion Services Lab of Central Blood Bank." Harvard Business School Case 693-091, May 1993.
      • April 1993 (Revised November 1994)
      • Case

      Chiron Corp.

      By: Steven C. Wheelwright
      Pablo Valenzuela, vice president of R&D at Chiron Corp., faces several choices for how to allocate scarce resources across several promising projects. These choices will determine Chiron's position in several emerging biotechnology and diagnostic markets, including... View Details
      Keywords: Health Testing and Trials; Research and Development; Failure; Business Strategy; Joint Ventures; Strategic Planning; Opportunities; Product Development; Biotechnology Industry; California
      Citation
      Find at Harvard
      Related
      Wheelwright, Steven C. "Chiron Corp." Harvard Business School Case 693-052, April 1993. (Revised November 1994.)
      • November 1991 (Revised April 1994)
      • Case

      Nucleon, Inc.

      By: Gary P. Pisano
      Nucleon is a small biotechnology company whose first potential product is about to enter clinical testing. Before Nucleon can begin clinical trials, however, its management must decide how and where to manufacture the product. Three options are being contemplated: 1)... View Details
      Keywords: Factories, Labs, and Plants; Entrepreneurship; Health Testing and Trials; Rights; Product Development; Production; Partners and Partnerships; Research and Development; Biotechnology Industry
      Citation
      Educators
      Purchase
      Related
      Pisano, Gary P. "Nucleon, Inc." Harvard Business School Case 692-041, November 1991. (Revised April 1994.)
      • September 1991 (Revised August 1994)
      • Background Note

      Note on Pharmaceutical Industry Regulation

      By: Willis M. Emmons III
      Traces the evolution of U.S. regulatory policy towards the pharmaceutical industry over the course of the twentieth century. A major theme is the steady shift away from a policy of 'let the buyer beware' to the creation of a complex and time-consuming review process,... View Details
      Keywords: Safety; Industry Growth; Marketing; Research and Development; Health Testing and Trials; Economics; Pharmaceutical Industry; United States
      Citation
      Find at Harvard
      Related
      Emmons, Willis M., III. "Note on Pharmaceutical Industry Regulation." Harvard Business School Background Note 792-002, September 1991. (Revised August 1994.)
      • 1984
      • Book

      The Results and Interpretation of Three Field Trials of Lysine Fortification of Cereals

      By: James E. Austin, Jean Pierre Habicht, Max Milner, Vernon Young and Linda D. Myers
      Keywords: Food; Nutrition
      Citation
      Find at Harvard
      Related
      Austin, James E., Jean Pierre Habicht, Max Milner, Vernon Young, and Linda D. Myers. The Results and Interpretation of Three Field Trials of Lysine Fortification of Cereals. Washington, D.C.: National Academy Press, 1984.
      • Article

      Physician-Induced Demand for Medical Care

      By: Jerry R. Green
      This paper addresses the theoretical models designed to ascertain the existence of a variable level of physicians' activity in shifting the demand of their patients. Two basic approaches are followed: equilibrium models of the demand for health care, and disequilibrium... View Details
      Keywords: Physicians; Economic Equilibrium; Monopolistic Competition; Economic Competition; Medical Care
      Citation
      Find at Harvard
      Read Now
      Related
      Green, Jerry R. "Physician-Induced Demand for Medical Care." Special Issue on National Bureau of Economic Research Conference on the Economics of Physician and Patient Behavior. Journal of Human Resources 13, Suppl. (1978).
      • October 1976 (Revised February 1987)
      • Case

      Cramer Electronics, Inc.

      By: Michael E. Porter
      Designed to be the second day of a two-day series on the electronic component distribution industry, following a day spent discussing Note on the Electronic Component Distribution Industry and Raytheon Co.: Diversification. The important teaching themes which this case... View Details
      Keywords: Change Management; Innovation Strategy; Management Style; Resource Allocation; Opportunities; Corporate Strategy; Diversification; Distribution Industry; Electronics Industry
      Citation
      Educators
      Purchase
      Related
      Porter, Michael E. "Cramer Electronics, Inc." Harvard Business School Case 377-063, October 1976. (Revised February 1987.)
      • ←
      • 9

      Are you looking for?

      →Search All HBS Web
      ǁ
      Campus Map
      Harvard Business School
      Soldiers Field
      Boston, MA 02163
      →Map & Directions
      →More Contact Information
      • Make a Gift
      • Site Map
      • Jobs
      • Harvard University
      • Trademarks
      • Policies
      • Accessibility
      • Digital Accessibility
      Copyright © President & Fellows of Harvard College.